Results from a phase I/II trial of tinostamustine monotherapy in advanced solid tumours (NCT03345485): Safety and efficacy in a subset of patients (pts) with soft tissue sarcoma (STS)

被引：0
|
作者：
Chugh, R. [1 ]
Kummar, S. [2 ]
Schneider, R. E. [3 ]
Janik, T. [4 ]
Manamley, N. [5 ]
Hilgier, K. [4 ]
Strauss, J. [3 ]
机构：
[1] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI USA
[2] OHSU Knight Canc Inst, Div Hematol & Med Oncol, Ctr Hlth & Healing, Bldg 1 South Waterfront, Portland, OR USA
[3] Mary Crowley Canc Res Ctr, Med Oncol Dept, Dallas, TX USA
[4] Mundipharma Res Ltd, Clin Dev Oncol & Hematol, Cambridge, England
[5] Mundipharma Int, R&D, Cambridge, England
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.1186
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1957P
引用
收藏
页码：S1048 / S1048
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetics and safety of olaparib tablets as monotherapy and in combination with paclitaxel: results of a Phase I study in Chinese patients with advanced solid tumours
    Yuan, Peng
    Shentu, Jianzhong
    Xu, Jianming
    Burke, Wendy
    Hsu, Kate
    Learoyd, Maria
    Zhu, Min
    Xu, Binghe
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (05) : 963 - 974
  • [22] Phase I-II trial of intensification of the MAID regimen with support of lenograstim (rHuG-CSF) in patients with advanced soft-tissue sarcoma (STS)
    Chevreau, C
    Bui, BN
    Chevallier, B
    Krakowski, I
    Maugard, C
    Mihura, J
    Coindre, JM
    Gil, B
    Cour-Chabernaud, V
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (03): : 267 - 272
  • [23] Pharmacokinetics and safety of olaparib tablets as monotherapy and in combination with paclitaxel: results of a Phase I study in Chinese patients with advanced solid tumours
    Peng Yuan
    Jianzhong Shentu
    Jianming Xu
    Wendy Burke
    Kate Hsu
    Maria Learoyd
    Min Zhu
    Binghe Xu
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 963 - 974
  • [24] Efficacy and safety of nivolumab and trabectedin in pretreated patients with advanced soft tissue sarcomas (STS): Preliminary results of a phase II trial of the German Interdisciplinary Sarcoma Group (GISG-15, NitraSarc) for the non-L sarcoma cohort.
    Pink, Daniel
    Andreou, Dimosthenis
    Florcken, Anne
    Golf, Alexander
    Richter, Stephan
    Kessler, Torsten
    Kortum, Martin
    Schmidt, Christian Andreas
    Kasper, Bernd
    Wardelmann, Eva
    Bahr, Jeanette
    Mueller, Daniel Wilhelm
    Sookthai, Disorn
    Al-Batran, Salah-Eddin
    Reichardt, Peter
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [25] A phase I/II trial of the PD-1 inhibitor retifanlimab (R) in combination with gemcitabine and docetaxel (GD) as first-line therapy in patients (Pts) with advanced soft-tissue sarcoma (STS).
    Rosenbaum, Evan
    Qin, Xuan
    Thornton, Katherine Anne
    Movva, Sujana
    Nacev, Benjamin Alexander
    Dickson, Mark Andrew
    Gounder, Mrinal M.
    Keohan, Mary Louise
    Avutu, Viswatej
    Chi, Ping
    Kelly, Ciara Marie
    Chan, Jason Earl
    Martindale, Moriah
    Adamson, Travis
    McKennan, Olivia Robin
    Erinjeri, Joseph Patrick
    Lefkowitz, Robert A.
    Tap, William D.
    D'Angelo, Sandra P.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [26] A phase II trial of AP23573, a novel mTOR inhibitor, in patients (Pts) with advanced soft tissue or bone sarcoma.
    Chawla, SP
    Blay, JY
    Staddon, AP
    D'Amato, GZ
    Tolcher, AW
    Sankhala, KK
    Daly, ST
    Bedrosian, CL
    Demetri, GD
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9166S - 9166S
  • [27] A phase I clinical trial of belinostat (PXD101) in combination with doxorubicin (BelDox) in advanced solid tumours, including soft tissue sarcomas (STS)
    Brunetto, A. T.
    Krarup-Hansen, A.
    Nielsen, O. S.
    Norman, A.
    Safwat, A.
    Tjornelund, J.
    Judson, I.
    EJC SUPPLEMENTS, 2008, 6 (12): : 132 - 132
  • [28] Phase I trial to investigate the safety, pharmacokinetics and efficacy of sorafenib combined with docetaxel in patients with advanced refractory solid tumours
    Awada, Ahmad
    Hendlisz, Alain
    Christensen, Olaf
    Lathia, Chetan D.
    Bartholomeus, Sylvie
    Lebrun, Fabienne
    de Valeriola, Dominique
    Brendel, Erich
    Radtke, Martin
    Delaunoit, Thierry
    Piccart-Gebhart, Martine
    Gil, Thierry
    EUROPEAN JOURNAL OF CANCER, 2012, 48 (04) : 465 - 474
  • [29] Safety and Tolerability of AZD0466 As Monotherapy for Patients with Advanced Hematologic Malignancies. Results from a Phase I/II Trial
    Arslan, Shukaib
    Marconi, Giovanni
    Martinelli, Giovanni
    Fleming, Shaun
    Curti, Antonio
    Dinner, Shira N.
    Blachly, James S.
    Della Porta, Matteo Giovanni
    Bajel, Ashish
    Sauer, Tim
    Crysandt, Martina
    Pigneux, Arnaud
    Fransecky, Lars
    Baldus, Claudia D.
    Konopleva, Marina Y.
    Marmor, Yotvat
    Sharma, Shringi
    Elgeioushi, Nairouz
    Cheung, Patricia
    Rowe, Emily
    Jahn, Ekaterina
    Yu, Ting
    Saeh, Jamal
    Tibes, Raoul
    Cader, Fathima Zumla
    Jain, Nitin
    BLOOD, 2023, 142
  • [30] A phase II trial of panobinostat in patients with advanced pretreated soft tissue sarcoma. A study from the French Sarcoma Group
    Cassier, P. A.
    Lefranc, A.
    Amela, E. Y.
    Chevreau, C.
    Bui, B. N.
    Lecesne, A.
    Ray-Coquard, I.
    Chabaud, S.
    Penel, N.
    Berge, Y.
    Domont, J.
    Italiano, A.
    Duffaud, F.
    Cadore, A-C
    Polivka, V.
    Blay, J-Y
    BRITISH JOURNAL OF CANCER, 2013, 109 (04) : 909 - 914
12345